Replies to post #252388 on Biotech Values

[Mufaso]

meaning that adults aged 60–74 years without risk factors for severe RSV disease, are no longer recommended to receive RSV vaccination”

Really appreciate your and Dew's comments on the RSV Vaccine both for investment reasons as well as personnel reasons. My doctor recommended I get the vaccine some time ago. I was originally waiting to find out which vax was going to be the best for me. From what I've read and your posts, It sounds like the GBS risk is not trivial. This is leading me to continue to pass on this as an investment now as well as a therapy although I may change my mind on both counts.